These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 473681)

  • 21. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alteration in content of lipids and lipoproteins in blood of rabbits with experimental allergic polyneuritis and encephalomyelitis].
    Pleskov VM; Triufanov VF; Khitnukhin IuL; Konovalov GV
    Vopr Med Khim; 1981; 27(3):376-80. PubMed ID: 6169201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide.
    Hoffman PM; Gaston DD; Spitler LE
    Clin Immunol Immunopathol; 1973 Apr; 1(3):364-71. PubMed ID: 4127172
    [No Abstract]   [Full Text] [Related]  

  • 24. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute demyelination in EAE after pretreatment with foreign protein and muramyl dipeptide (MDP).
    Colover J
    Prog Clin Biol Res; 1984; 146():37-42. PubMed ID: 6718428
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic experimental allergic encephalomyelitis in guinea pigs induced by proteolipid protein.
    Yoshimura T; Kunishita T; Sakai K; Endoh M; Namikawa T; Tabira T
    J Neurol Sci; 1985; 69(1-2):47-58. PubMed ID: 2409237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental allergic encephalomyelitis: species variability of the encephalitogenic determinant.
    Swanborg RH; Amesse LS
    J Immunol; 1971 Jul; 107(1):281-3. PubMed ID: 4103918
    [No Abstract]   [Full Text] [Related]  

  • 28. An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system.
    Prineas J; Raine CS; Wísniewski H
    Lab Invest; 1969 Dec; 21(6):472-83. PubMed ID: 5356782
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
    Whitacre CC; Paterson PY
    J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunoluminescent study of the sera of guinea pigs with experimental allergic encephalomyelitis].
    Zhitnukhin IuL; Zubzhitskiĭ IuN
    Biull Eksp Biol Med; 1972 Aug; 73(8):63-5. PubMed ID: 4564367
    [No Abstract]   [Full Text] [Related]  

  • 31. Antigen-induced inhibition of experimental allergic encephalomyelitis. I. Inhibition in guinea pigs injected with non-encephalitogenic modified myelin basic protein.
    Swanborg RH
    J Immunol; 1972 Sep; 109(3):540-6. PubMed ID: 4626655
    [No Abstract]   [Full Text] [Related]  

  • 32. [Intensity of phospholipid and cholesterol synthesis in the brain and spinal cord of rabbits with experimental allergic encephelomyelitis].
    Taranova NN; Katsnel'son IP
    Biull Eksp Biol Med; 1976 Mar; 81(3):291-3. PubMed ID: 953270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.
    Akiyama K; Murakami T; Nomaguchi TA; Nagai Y
    Jpn J Exp Med; 1981 Apr; 51(2):137-9. PubMed ID: 6168789
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental allergic encephalomyelitis as model of a neuro-allergic disease].
    Hitzschke B; Meyer-Rienecker H; Sayk J; Schröter P
    Z Arztl Fortbild (Jena); 1969 Dec; 63(24):1315-20. PubMed ID: 5403442
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mechanism of action of an encephalitogenic polypeptide in induction of experimental allergic encephalitis].
    Lamoureux G; Carnegie PR; McPherson TA; Mackay IR; Bernard C
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):562-74. PubMed ID: 5421297
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood-cerebrospinal fluid barrier permeability changes in guinea pigs inoculated for chronic relapsing experimental allergic encephalomyelitis or with adjuvant alone.
    Suckling AJ; Reiber H; Kirby JA; Rumsby MG
    Prog Clin Biol Res; 1984; 146():75-80. PubMed ID: 6718435
    [No Abstract]   [Full Text] [Related]  

  • 37. [Incorporation of 14C from glucose into proteins, lipids and amino acids in sections of grey matter of the brain of guinea pigs in experimental allergic encephalomyelitis].
    Zachar F; Turský T
    Biologia (Bratisl); 1968; 23(3):220-8. PubMed ID: 5668838
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction of experimental allergic encephalomyelitis in the goat.
    Purdy CW; Loan RW
    Am J Vet Res; 1969 Jan; 30(1):85-9. PubMed ID: 5782569
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of antilymphocyte sera on the development of experimental allergic encephalomyelitis].
    Zhitnukhin IuL; Baĭkovskaia MN
    Biull Eksp Biol Med; 1976 Jul; 82(7):844-7. PubMed ID: 953349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Disordered permeability of the hemato-encephalic barrier in the development of allergic processes of the nervous system].
    Zhitnukhin IuL; Sofronov BN
    Patol Fiziol Eksp Ter; 1989; (5):44-7. PubMed ID: 2482476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.